Viewing nowNeurica Capsule 300 mg (Pregabalin)
Pregabalin 300mg
Hard capsule · Prescription medication
Dong-A ST Co., Ltd.

MFDS item code 201706376 · Approved 2017.07.31 · Insurance code 642507450
Treatment of neuropathic pain and fibromyalgia; adjunctive treatment of partial-onset seizures
This medication is used to treat peripheral and central neuropathic pain in adults and serves as an adjunctive for partial seizures in patients with epilepsy, whether or not accompanied by generalized symptoms. It is also effective for the treatment of fibromyalgia, helping to relieve patients' pain.
Administer the total daily dose of pregabalin orally in 2 divided doses, with or without food. 1. Neuropathic pain 1) Peripheral neuropathic pain Adults: The starting dose is 150 mg per day. Based on each patient’s response and tolerability, the dose may be increased to 300 mg per day after 3 to 7 days. If necessary, the dose may then be increased at 7-day intervals up to a maximum of 600 mg per day. 2) Central neuropathic pain Adults: The starting dose is 150 mg per day. Based on each patient’s response and tolerability, the dose may be increased to 300 mg per day after 1 week. After an additional week, it may be increased to the target dose of 600 mg per day. If the target daily dose is not tolerated, dose reduction may be considered. (See section “4. Discontinuation of Treatment”) 2. Epilepsy Adults: The starting dose is 150 mg per day. Based on each patient’s response and tolerability, the dose may be increased to 300 mg per day after 1 week. If necessary, the dose may then be increased at 7-day intervals up to a maximum of 600 mg per day. 3. Fibromyalgia The recommended dose for fibromyalgia is 300 mg to 450 mg per day. The starting dose is 75 mg twice daily (150 mg per day), and based on efficacy and tolerability, it may be increased within 1 week to 150 mg twice daily (300 mg per day). For patients who do not experience sufficient benefit at 300 mg per day, the dose may be increased within 1 week to 225 mg twice daily (450 mg per day). Clinical studies have also been conducted at a dose of 600 mg per day, but there is no evidence of additional benefit or adequate tolerability at this dose. In view of dose-dependent adverse reactions, doses exceeding 450 mg per day are not recommended. 4. Discontinuation of Treatment Based on current clinical experience, if treatment with this medicine is discontinued, it should be tapered gradually over at least 1 week. 5. Patients with Renal Impairment Dose reduction in patients with impaired renal function should be individualized based on creatinine clearance. [Table 1]. Pregabalin dosage based on renal function Creatinine clearance (CLcr), (mL/min) ≥60: Starting dose 150 (mg/day), maximum dose 600 (mg/day), BID or TID ≥30 -<60: Starting dose 75 (mg/day), maximum dose 300 (mg/day), BID or TID ≥15 -<30: Starting dose 25-50 (mg/day), maximum dose 150 (mg/day), QD or BID <15: Starting dose 25 (mg/day), maximum dose 75 (mg/day), QD Supplemental dose after hemodialysis: 25-100, single dose TID = total daily dose divided into 3 doses BID = total daily dose divided into 2 doses QD = once daily a: The total daily dose (mg/day) should be divided as indicated by the dosing regimen. b: The supplemental dose refers to an additional dose given as a single dose. 6. Patients with Hepatic Impairment Dose adjustment is not necessary in patients with hepatic impairment. 8. Older Adults (65 years of age or older) Dose reduction may be necessary in older adults with impaired renal function.
There are insufficient safety and efficacy data for children under 12 years of age and adolescents aged 12 to 17 years; therefore, use is not recommended.
This medication may increase the risk of suicidal thoughts or behaviors, so any changes in mood or behavior during treatment should be reported to a healthcare professional immediately. Patients with allergies to any of the ingredients should not take this medication, and those with certain genetic conditions, such as lactose intolerance, should also avoid it. Diabetic patients should be cautious as weight gain may necessitate adjustments in diabetes control medications. If symptoms of angioedema occur, discontinue use immediately and consult a physician. Elderly patients may be at higher risk of falls due to dizziness or drowsiness; they should be careful until they are accustomed to the drug's effects. Blurred vision or changes in eyesight may occur, but these symptoms may improve upon discontinuation of the drug. Abrupt cessation of this medication may induce withdrawal symptoms such as insomnia, headache, or anxiety; thus it should be gradually discontinued under a doctor's guidance. There is a risk of drug abuse; patients with a history of drug abuse or mental illness should be particularly cautious. Patients with reduced kidney function may require dosage adjustments. Individuals with cardiac conditions should be vigilant while taking this medication. Caution is advised when taken with opioid analgesics due to increased risk of CNS depression. Patients with respiratory or central nervous system conditions, kidney impairment, and elderly patients may have an increased risk of severe respiratory depression, thus dosage adjustments may be necessary. Pregnant women should avoid this medication in early pregnancy due to the risk of fetal malformations, and women of childbearing age should use effective contraception. Breastfeeding women should consider that this drug can be transmitted through breast milk, and may need to discontinue breastfeeding or the medication. Care should be taken when driving or operating machinery due to risks from dizziness and drowsiness. Severe skin reactions may rarely occur, and if abnormal skin symptoms arise, the medication should be discontinued immediately. Overdose may result in symptoms such as drowsiness, confusion, and depression; treatment such as dialysis may be required if necessary. Keep out of reach of children and do not transfer the medicine to another container.
suicidal impulses, suicidal behavior, depression, abnormal changes in mood and behavior, angioedema, facial swelling, perioral edema, upper respiratory tract edema, dizziness, drowsiness, loss of consciousness, confusion, mental disorders, blurred vision, changes in vision, insomnia, headache, nausea, anxiety, diarrhea, influenza-like symptoms, restlessness, suicidal thoughts, pain, seizures, hyperhidrosis, misuse, abuse, dependence, congestive heart failure, severe respiratory depression, rhinitis, neutropenia, increased appetite, reduced appetite, hypoglycemia, confusion, directional disorientation, irritability, sense of elation, decreased libido, depersonalization, sexual hypersensitivity, agitation, mood disturbance, emotional dysregulation, emotional elevation, hallucinations, abnormal dreams, increased libido, panic attacks, inability to inhibit, apathy, ataxia, coordination disorders, balance disorders, amnesia, attention disorders, memory disorders, tremors, speech disorders, sensory abnormalities, sensory reduction, sedation, hypersomnolence, cognitive impairment, nystagmus, language disorders, myoclonus, decreased reflexes, motor disturbances, psychomotor agitation, positional dizziness, hypersensitivity, burning sensation, activity tremors, syncope, confusion, hypokinesia, olfactory abnormalities, loss of taste, writing disorders, blurred vision, diplopia, loss of peripheral vision, visual disturbance, visual field defects, photopsia, dry eyes, ocular swelling, reduced vision, eye pain, eye fatigue, increased tear secretion, eye irritation, mydriasis, recognition changes in depth of field during vibration, strabismus, visual brightness, vertigo, auditory hypersensitivity, first-degree atrioventricular block, tachycardia, sinus bradycardia, sinus tachycardia, sinus arrhythmia, hypotension, hypertension, flushing, facial flushing, peripheral coldness, dyspnea, epistaxis, cough, nasal congestion, rhinitis, snoring, throat tension, nasal dryness, respiratory depression, vomiting, abdominal distension, constipation, dry mouth, abdominal swelling, excessive salivation, gastroesophageal reflux disease, oral sensory reduction, ascites, dysphagia, pancreatitis, sweating, papular rash, urticaria, cold sweat, muscle cramps, arthralgia, back pain, limb pain, cervical cramps, joint swelling, myalgia, muscle spasms, neck pain, muscle stiffness, rhabdomyolysis, urinary disorders, urinary incontinence, decreased urination, renal failure, erectile dysfunction, delayed ejaculation, sexual dysfunction, dysmenorrhea, amenorrhea, mastalgia, breast discharge, gynecomastia, peripheral edema, edema, gait abnormalities, falls, feeling intoxicated, altered sensation, fatigue, chest tightness, generalized edema, pain, fever, chills, weakness, thirst, weight gain, increased alanine aminotransferase, increased serum creatine phosphokinase, increased aspartate aminotransferase, increased blood glucose, decreased platelet count, decreased serum potassium, weight loss, increased serum creatinine, decreased white blood cell count, hypersensitivity, allergic reactions, headache, keratitis, pulmonary edema, nausea, diarrhea, tongue swelling, itching, Stevens-Johnson syndrome, toxic epidermal necrolysis, urinary retention, gynecomastia, lethargy, delirium, paralysis (facial paralysis), affective disorder, drowsiness, confusion, depression, agitation, restlessness, worsening of spasms, gastrointestinal disturbances, tinnitus, sleep disorders, skin diseases, increased BUN, bloody stools, colorectal cancer, gastroenteritis, pneumonia
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly closed container to prevent air and moisture from entering, in a cool place between 15 degrees and 30 degrees Celsius. Proper storage will help maintain the efficacy of the medication for a longer period.
Hard capsule with a reddish-brown upper part and a white lower part containing a white or pale yellow powder
30 capsules/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowPregabalin 300mg
Hard capsule · Prescription medication
Dong-A ST Co., Ltd.

Pregabalin 75mg
Hard capsule · Prescription medication
Viatris Korea Co., Ltd.

Pregabalin 150mg
Hard capsule · Prescription medication
Viatris Korea Co., Ltd.

Pregabalin 300mg
Hard capsule · Prescription medication
Viatris Korea Co., Ltd.

Pregabalin 150mg
Hard capsule · Prescription medication
Samjin Pharmaceutical Co., Ltd.

Pregabalin 75mg
Hard capsule · Prescription medication
Samjin Pharmaceutical Co., Ltd.

Pregabalin 75mg
Hard capsule · Prescription medication
Hanmi Pharm. Co., Ltd.

Pregabalin 150mg
Hard capsule · Prescription medication
Hanmi Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.